Last 12 months
Inside the activity.
1 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 1 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 01, 2022 Filed Dec 1, 2022 21:50 UTC |
Zamiri ParisaChief Medical Officer
|
Tax withholdingCommon Stock | 2,752 | $0.63 | $1,733.76 |
DisclosureSEC source: 0001209191-22-059206 · doc4.xml · nonDerivative · entry 2 Zamiri Parisa · CIK 0001824806 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,577 Read SEC document |
| December 01, 2022 Filed Dec 1, 2022 21:50 UTC |
Zamiri ParisaChief Medical Officer
|
Exercise / conversionCommon Stock | 9,375 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-059206 · doc4.xml · nonDerivative · entry 1 Zamiri Parisa · CIK 0001824806 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,329 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| December 01, 2022 Filed Dec 1, 2022 21:49 UTC |
Guerard FredericDirector · Chief Executive Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 28,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-059205 · doc4.xml · derivative · entry 3 Guerard Frederic · CIK 0001825009 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 281,250 Underlying: Common Stock · 28,125 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: The RSUs vested as to 1/4 of the total shares on May 19, 2022, and 1/16 of the remaining shares shall vest quarterly thereafter such that the RSUs shall be fully vested on May 19, 2025, subject to the continued service of the Reporting Person to the Issuer through each vesting date. F3 · derivative.expiration_date: The RSUs do not expire; they either vest or are canceled prior to vest date. Read SEC document |
| December 01, 2022 Filed Dec 1, 2022 21:49 UTC |
Guerard FredericDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 11,068 | $0.63 | $6,972.84 |
DisclosureSEC source: 0001209191-22-059205 · doc4.xml · nonDerivative · entry 2 Guerard Frederic · CIK 0001825009 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,530 Read SEC document |
| December 01, 2022 Filed Dec 1, 2022 21:49 UTC |
Guerard FredericDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 28,125 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-059205 · doc4.xml · nonDerivative · entry 1 Guerard Frederic · CIK 0001825009 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168,598 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| November 24, 2022 Filed Nov 29, 2022 16:38 UTC |
BREUIL ROBERT SChief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 28,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-058951 · doc4.xml · derivative · entry 3 BREUIL ROBERT S · CIK 0001241009 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 421,875 Underlying: Common Stock · 28,125 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: The RSUs shall vested as to 6.25% of the total shares on November 16, 2022, and 6.25% of the remaining shares shall vest quarterly thereafter such that the RSUs shall be fully vested on August 16, 2026, subject to the continued service of the Reporting Person to the Issuer through each vesting date. F3 · derivative.expiration_date: The RSUs do not expire; they either vest or are canceled prior to vest date. Read SEC document |
| November 24, 2022 Filed Nov 29, 2022 16:38 UTC |
BREUIL ROBERT SChief Financial Officer
|
Tax withholdingCommon Stock | 9,726 | $0.67 | $6,516.42 |
DisclosureSEC source: 0001209191-22-058951 · doc4.xml · nonDerivative · entry 2 BREUIL ROBERT S · CIK 0001241009 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,294 Read SEC document |
| November 24, 2022 Filed Nov 29, 2022 16:38 UTC |
BREUIL ROBERT SChief Financial Officer
|
Exercise / conversionCommon Stock | 28,125 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-058951 · doc4.xml · nonDerivative · entry 1 BREUIL ROBERT S · CIK 0001241009 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,020 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| November 24, 2022 Filed Nov 29, 2022 21:36 UTC |
Guerard FredericDirector · Chief Executive Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 65,625 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-058949 · doc4.xml · derivative · entry 3 Guerard Frederic · CIK 0001825009 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 984,375 Underlying: Common Stock · 65,625 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: The RSUs shall vested as to 6.25% of the total shares on November 16, 2022, and 6.25% of the remaining shares shall vest quarterly thereafter such that the RSUs shall be fully vested on August 16, 2026, subject to the continued service of the Reporting Person to the Issuer through each vesting date. F3 · derivative.expiration_date: The RSUs do not expire; they either vest or are canceled prior to vest date. Read SEC document |
| November 24, 2022 Filed Nov 29, 2022 21:36 UTC |
Guerard FredericDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 25,824 | $0.67 | $17,302.08 |
DisclosureSEC source: 0001209191-22-058949 · doc4.xml · nonDerivative · entry 2 Guerard Frederic · CIK 0001825009 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,473 Read SEC document |
| November 24, 2022 Filed Nov 29, 2022 21:36 UTC |
Guerard FredericDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 65,625 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-058949 · doc4.xml · nonDerivative · entry 1 Guerard Frederic · CIK 0001825009 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 166,297 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| November 24, 2022 Filed Nov 29, 2022 21:37 UTC |
Zamiri ParisaChief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 28,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-058950 · doc4.xml · derivative · entry 3 Zamiri Parisa · CIK 0001824806 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 421,875 Underlying: Common Stock · 28,125 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: The RSUs shall vested as to 6.25% of the total shares on November 16, 2022, and 6.25% of the remaining shares shall vest quarterly thereafter such that the RSUs shall be fully vested on August 16, 2026, subject to the continued service of the Reporting Person to the Issuer through each vesting date. F3 · derivative.expiration_date: The RSUs do not expire; they either vest or are canceled prior to vest date. Read SEC document |
| November 24, 2022 Filed Nov 29, 2022 21:37 UTC |
Zamiri ParisaChief Medical Officer
|
Tax withholdingCommon Stock | 8,255 | $0.67 | $5,530.85 |
DisclosureSEC source: 0001209191-22-058950 · doc4.xml · nonDerivative · entry 2 Zamiri Parisa · CIK 0001824806 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,954 Read SEC document |
| November 24, 2022 Filed Nov 29, 2022 21:37 UTC |
Zamiri ParisaChief Medical Officer
|
Exercise / conversionCommon Stock | 28,125 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-058950 · doc4.xml · nonDerivative · entry 1 Zamiri Parisa · CIK 0001824806 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,209 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| September 23, 2022 Filed Sep 26, 2022 16:17 UTC |
BREUIL ROBERT SChief Financial Officer
|
Tax withholdingCommon Stock | 1,684 | $0.97 | $1,626.91 |
DisclosureSEC source: 0001209191-22-051242 · doc4.xml · nonDerivative · entry 2 BREUIL ROBERT S · CIK 0001241009 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,895 Read SEC document |
| September 04, 2022 Filed Sep 26, 2022 16:17 UTC |
BREUIL ROBERT SChief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-051242 · doc4.xml · derivative · entry 3 BREUIL ROBERT S · CIK 0001241009 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 5,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: The RSUs vested as to 1/12 of the total shares on September 4, 2022, but were not settled and issued until September 23, 2022. 1/12 of the remaining shares shall vest quarterly thereafter such that the RSUs shall be fully vested on September 4, 2024, subject to the continued service of the Reporting Person to the Issuer through each vesting date. F3 · derivative.expiration_date: The RSUs do not expire; they either vest or are canceled prior to vest date. Read SEC document |
| September 04, 2022 Filed Sep 26, 2022 16:17 UTC |
BREUIL ROBERT SChief Financial Officer
|
Exercise / conversionCommon Stock | 5,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-051242 · doc4.xml · nonDerivative · entry 1 BREUIL ROBERT S · CIK 0001241009 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,579 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| August 24, 2022 Filed Aug 26, 2022 16:49 UTC |
BREUIL ROBERT SChief Financial Officer
|
GrantRestricted Stock Units · Derivative | 450,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-047724 · doc4.xml · derivative · entry 1 BREUIL ROBERT S · CIK 0001241009 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 450,000 Underlying: Common Stock · 450,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: The RSUs shall vest as to 6.25% of the total shares on November 16, 2022, and 6.25% of the remaining shares shall vest quarterly thereafter such that the RSUs shall be fully vested on August 16, 2026, subject to the continued service of the Reporting Person to the Issuer through each vesting date. F3 · derivative.expiration_date: The RSUs do not expire; they either vest or are canceled prior to vest date. Read SEC document |
| August 24, 2022 Filed Aug 26, 2022 20:49 UTC |
Zamiri ParisaChief Medical Officer
|
GrantRestricted Stock Units · Derivative | 450,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-047723 · doc4.xml · derivative · entry 1 Zamiri Parisa · CIK 0001824806 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 450,000 Underlying: Common Stock · 450,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: The RSUs shall vest as to 6.25% of the total shares on November 16, 2022, and 6.25% of the remaining shares shall vest quarterly thereafter such that the RSUs shall be fully vested on August 16, 2026, subject to the continued service of the Reporting Person to the Issuer through each vesting date. F3 · derivative.expiration_date: The RSUs do not expire; they either vest or are canceled prior to vest date. Read SEC document |
| August 24, 2022 Filed Aug 26, 2022 20:48 UTC |
Guerard FredericDirector · Chief Executive Officer
|
GrantRestricted Stock Units · Derivative | 1,050,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-047722 · doc4.xml · derivative · entry 1 Guerard Frederic · CIK 0001825009 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,050,000 Underlying: Common Stock · 1,050,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: The RSUs shall vest as to 6.25% of the total shares on November 16, 2022, and 6.25% of the remaining shares shall vest quarterly thereafter such that the RSUs shall be fully vested on August 16, 2026, subject to the continued service of the Reporting Person to the Issuer through each vesting date. F3 · derivative.expiration_date: The RSUs do not expire; they either vest or are canceled prior to vest date. Read SEC document |
| August 19, 2022 Filed Aug 23, 2022 17:17 UTC |
BREUIL ROBERT SChief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 9,937 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-047234 · doc4.xml · derivative · entry 3 BREUIL ROBERT S · CIK 0001241009 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,313 Underlying: Common Stock · 9,937 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: The RSUs vested as to 1/4 of the total shares on May 19, 2022, and 1/16 of the remaining shares shall vest quarterly thereafter such that the RSUs shall be fully vested on May 19, 2025, subject to the continued service of the Reporting Person to the Issuer through each vesting date. F3 · derivative.expiration_date: The RSUs do not expire; they either vest or are canceled prior to vest date. Read SEC document |
| August 19, 2022 Filed Aug 23, 2022 17:17 UTC |
BREUIL ROBERT SChief Financial Officer
|
Tax withholdingCommon Stock | 3,347 | $0.97 | $3,246.59 |
DisclosureSEC source: 0001209191-22-047234 · doc4.xml · nonDerivative · entry 2 BREUIL ROBERT S · CIK 0001241009 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,579 Read SEC document |
| August 19, 2022 Filed Aug 23, 2022 17:17 UTC |
BREUIL ROBERT SChief Financial Officer
|
Exercise / conversionCommon Stock | 9,937 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-047234 · doc4.xml · nonDerivative · entry 1 BREUIL ROBERT S · CIK 0001241009 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,926 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| August 19, 2022 Filed Aug 23, 2022 21:16 UTC |
Zamiri ParisaChief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 9,375 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-047231 · doc4.xml · derivative · entry 3 Zamiri Parisa · CIK 0001824806 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,125 Underlying: Common Stock · 9,375 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: The RSUs vested as to 1/4 of the total shares on May 19, 2022, and 1/16 of the remaining shares shall vest quarterly thereafter such that the RSUs shall be fully vested on May 19, 2025, subject to the continued service of the Reporting Person to the Issuer through each vesting date. F3 · derivative.expiration_date: The RSUs do not expire; they either vest or are canceled prior to vest date. Read SEC document |
| August 19, 2022 Filed Aug 23, 2022 21:16 UTC |
Zamiri ParisaChief Medical Officer
|
Tax withholdingCommon Stock | 2,668 | $0.97 | $2,587.96 |
DisclosureSEC source: 0001209191-22-047231 · doc4.xml · nonDerivative · entry 2 Zamiri Parisa · CIK 0001824806 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,084 Read SEC document |
| August 19, 2022 Filed Aug 23, 2022 21:16 UTC |
Zamiri ParisaChief Medical Officer
|
Exercise / conversionCommon Stock | 9,375 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-047231 · doc4.xml · nonDerivative · entry 1 Zamiri Parisa · CIK 0001824806 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,752 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| August 19, 2022 Filed Aug 23, 2022 21:15 UTC |
Guerard FredericDirector · Chief Executive Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 28,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-047229 · doc4.xml · derivative · entry 3 Guerard Frederic · CIK 0001825009 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 309,375 Underlying: Common Stock · 28,125 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: The RSUs vested as to 1/4 of the total shares on May 19, 2022, and 1/16 of the remaining shares shall vest quarterly thereafter such that the RSUs shall be fully vested on May 19, 2025, subject to the continued service of the Reporting Person to the Issuer through each vesting date. F3 · derivative.expiration_date: The RSUs do not expire; they either vest or are canceled prior to vest date. Read SEC document |
| August 19, 2022 Filed Aug 23, 2022 21:15 UTC |
Guerard FredericDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 6,596 | $0.97 | $6,398.12 |
DisclosureSEC source: 0001209191-22-047229 · doc4.xml · nonDerivative · entry 2 Guerard Frederic · CIK 0001825009 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,672 Read SEC document |
| August 19, 2022 Filed Aug 23, 2022 21:15 UTC |
Guerard FredericDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 28,125 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-047229 · doc4.xml · nonDerivative · entry 1 Guerard Frederic · CIK 0001825009 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,268 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| June 09, 2022 Filed Jun 13, 2022 17:06 UTC |
BREUIL ROBERT SChief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-036381 · doc4.xml · derivative · entry 2 BREUIL ROBERT S · CIK 0001241009 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 5,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: The RSUs vested as to 1/4 of the total shares on September 4, 2021 but did not settle until September 22, 2021. 1/12 of the remaining shares shall vest quarterly thereafter such that the RSUs shall be fully vested on September 4, 2024, subject to the continued service of the Reporting Person to the Issuer through each vesting date. F3 · derivative.expiration_date: The RSUs do not expire; they either vest or are canceled prior to vest date. Read SEC document |
| June 09, 2022 Filed Jun 13, 2022 17:06 UTC |
BREUIL ROBERT SChief Financial Officer
|
Exercise / conversionCommon Stock | 5,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-036381 · doc4.xml · nonDerivative · entry 1 BREUIL ROBERT S · CIK 0001241009 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,989 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| June 02, 2022 Filed Jun 3, 2022 17:39 UTC |
SHAFFER CHRISTY LDirector
|
GrantRestricted Stock Units · Derivative | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-034262 · doc4.xml · derivative · entry 2 SHAFFER CHRISTY L · CIK 0001145929 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's Common Stock, subject to the reporting person's continued status as a service provider to the issuer. F1 · derivative.exercise_date: The award vests in full on the earlier of: (i) the one year anniversary of the grant date or (ii) the date of the issuer's 2023 Annual Meeting of its stockholders, subject to the reporting person's continuous service to the issuer on such date. F3 · derivative.expiration_date: These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date. Read SEC document |
| June 02, 2022 Filed Jun 3, 2022 17:39 UTC |
SHAFFER CHRISTY LDirector
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $0.98 | $0.00 |
DisclosureSEC source: 0001209191-22-034262 · doc4.xml · derivative · entry 1 SHAFFER CHRISTY L · CIK 0001145929 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2032-06-01 F1 · derivative.exercise_date: The award vests in full on the earlier of: (i) the one year anniversary of the grant date or (ii) the date of the issuer's 2023 Annual Meeting of its stockholders, subject to the reporting person's continuous service to the issuer on such date. Read SEC document |
| June 02, 2022 Filed Jun 3, 2022 17:36 UTC |
Sauer DirkDirector
|
GrantRestricted Stock Units · Derivative | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-034260 · doc4.xml · derivative · entry 2 Sauer Dirk · CIK 0001921165 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's Common Stock, subject to the reporting person's continued status as a service provider to the issuer. F1 · derivative.exercise_date: The award vests in full on the earlier of: (i) the one year anniversary of the grant date or (ii) the date of the issuer's 2023 Annual Meeting of its stockholders, subject to the reporting person's continuous service to the issuer on such date. F3 · derivative.expiration_date: These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date. Read SEC document |
| June 02, 2022 Filed Jun 3, 2022 17:36 UTC |
Sauer DirkDirector
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $0.98 | $0.00 |
DisclosureSEC source: 0001209191-22-034260 · doc4.xml · derivative · entry 1 Sauer Dirk · CIK 0001921165 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2032-06-01 F1 · derivative.exercise_date: The award vests in full on the earlier of: (i) the one year anniversary of the grant date or (ii) the date of the issuer's 2023 Annual Meeting of its stockholders, subject to the reporting person's continuous service to the issuer on such date. Read SEC document |
| June 02, 2022 Filed Jun 3, 2022 17:35 UTC |
EASTLAND JULIA MARIEDirector
|
GrantRestricted Stock Units · Derivative | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-034256 · doc4.xml · derivative · entry 2 EASTLAND JULIA MARIE · CIK 0001500189 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's Common Stock, subject to the reporting person's continued status as a service provider to the issuer. F1 · derivative.exercise_date: The award vests in full on the earlier of: (i) the one year anniversary of the grant date or (ii) the date of the issuer's 2023 Annual Meeting of its stockholders, subject to the reporting person's continuous service to the issuer on such date. F3 · derivative.expiration_date: These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date. Read SEC document |
| June 02, 2022 Filed Jun 3, 2022 17:35 UTC |
EASTLAND JULIA MARIEDirector
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $0.98 | $0.00 |
DisclosureSEC source: 0001209191-22-034256 · doc4.xml · derivative · entry 1 EASTLAND JULIA MARIE · CIK 0001500189 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2032-06-01 F1 · derivative.exercise_date: The award vests in full on the earlier of: (i) the one year anniversary of the grant date or (ii) the date of the issuer's 2023 Annual Meeting of its stockholders, subject to the reporting person's continuous service to the issuer on such date. Read SEC document |
| June 02, 2022 Filed Jun 3, 2022 21:32 UTC |
BJERKHOLT ERICDirector
|
GrantRestricted Stock Units · Derivative | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-034252 · doc4.xml · derivative · entry 2 BJERKHOLT ERIC · CIK 0001197350 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's Common Stock, subject to the reporting person's continued status as a service provider to the issuer. F1 · derivative.exercise_date: The award vests in full on the earlier of: (i) the one year anniversary of the grant date or (ii) the date of the issuer's 2023 Annual Meeting of its stockholders, subject to the reporting person's continuous service to the issuer on such date. F3 · derivative.expiration_date: These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date. Read SEC document |
| June 02, 2022 Filed Jun 3, 2022 21:32 UTC |
BJERKHOLT ERICDirector
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $0.98 | $0.00 |
DisclosureSEC source: 0001209191-22-034252 · doc4.xml · derivative · entry 1 BJERKHOLT ERIC · CIK 0001197350 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2032-06-01 F1 · derivative.exercise_date: The award vests in full on the earlier of: (i) the one year anniversary of the grant date or (ii) the date of the issuer's 2023 Annual Meeting of its stockholders, subject to the reporting person's continuous service to the issuer on such date. Read SEC document |
| June 02, 2022 Filed Jun 3, 2022 21:31 UTC |
ACKERMANN CHRISTINADirector
|
GrantRestricted Stock Units · Derivative | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-034247 · doc4.xml · derivative · entry 2 ACKERMANN CHRISTINA · CIK 0001681871 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's Common Stock, subject to the reporting person's continued status as a service provider to the issuer. F1 · derivative.exercise_date: The award vests in full on the earlier of: (i) the one year anniversary of the grant date or (ii) the date of the issuer's 2023 Annual Meeting of its stockholders, subject to the reporting person's continuous service to the issuer on such date. F3 · derivative.expiration_date: These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date. Read SEC document |
| June 02, 2022 Filed Jun 3, 2022 21:31 UTC |
ACKERMANN CHRISTINADirector
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $0.98 | $0.00 |
DisclosureSEC source: 0001209191-22-034247 · doc4.xml · derivative · entry 1 ACKERMANN CHRISTINA · CIK 0001681871 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2032-06-01 F1 · derivative.exercise_date: The award vests in full on the earlier of: (i) the one year anniversary of the grant date or (ii) the date of the issuer's 2023 Annual Meeting of its stockholders, subject to the reporting person's continuous service to the issuer on such date. Read SEC document |
| May 19, 2022 Filed May 23, 2022 16:48 UTC |
BREUIL ROBERT SChief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 39,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-031353 · doc4.xml · derivative · entry 3 BREUIL ROBERT S · CIK 0001241009 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,250 Underlying: Common Stock · 39,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: The RSUs vested as to 1/4 of the total shares on May 19, 2022, and 1/16 of the remaining shares shall vest quarterly thereafter such that the RSUs shall be fully vested on May 19, 2025, subject to the continued service of the Reporting Person to the Issuer through each vesting date. F3 · derivative.expiration_date: The RSUs do not expire; they either vest or are canceled prior to vest date. Read SEC document |
| May 19, 2022 Filed May 23, 2022 16:48 UTC |
BREUIL ROBERT SChief Financial Officer
|
Tax withholdingCommon Stock | 16,290 | $0.90 | $14,678.92 |
DisclosureSEC source: 0001209191-22-031353 · doc4.xml · nonDerivative · entry 2 BREUIL ROBERT S · CIK 0001241009 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,989 Read SEC document |
| May 19, 2022 Filed May 23, 2022 16:48 UTC |
BREUIL ROBERT SChief Financial Officer
|
Exercise / conversionCommon Stock | 39,750 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-031353 · doc4.xml · nonDerivative · entry 1 BREUIL ROBERT S · CIK 0001241009 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,279 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| May 19, 2022 Filed May 23, 2022 20:47 UTC |
Zamiri ParisaChief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 37,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-031350 · doc4.xml · derivative · entry 3 Zamiri Parisa · CIK 0001824806 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,500 Underlying: Common Stock · 37,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: The RSUs vested as to 1/4 of the total shares on May 19, 2022, and 1/16 of the remaining shares shall vest quarterly thereafter such that the RSUs shall be fully vested on May 19, 2025, subject to the continued service of the Reporting Person to the Issuer through each vesting date. F3 · derivative.expiration_date: The RSUs do not expire; they either vest or are canceled prior to vest date. Read SEC document |
| May 19, 2022 Filed May 23, 2022 20:47 UTC |
Zamiri ParisaChief Medical Officer
|
Tax withholdingCommon Stock | 13,123 | $0.90 | $11,825.14 |
DisclosureSEC source: 0001209191-22-031350 · doc4.xml · nonDerivative · entry 2 Zamiri Parisa · CIK 0001824806 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,377 Read SEC document |
| May 19, 2022 Filed May 23, 2022 20:47 UTC |
Zamiri ParisaChief Medical Officer
|
Exercise / conversionCommon Stock | 37,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-031350 · doc4.xml · nonDerivative · entry 1 Zamiri Parisa · CIK 0001824806 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| May 19, 2022 Filed May 23, 2022 20:46 UTC |
Guerard FredericDirector · Chief Executive Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 112,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-031348 · doc4.xml · derivative · entry 3 Guerard Frederic · CIK 0001825009 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 337,500 Underlying: Common Stock · 112,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: The RSUs vested as to 1/4 of the total shares on May 19, 2022, and 1/16 of the remaining shares shall vest quarterly thereafter such that the RSUs shall be fully vested on May 19, 2025, subject to the continued service of the Reporting Person to the Issuer through each vesting date. F3 · derivative.expiration_date: The RSUs do not expire; they either vest or are canceled prior to vest date. Read SEC document |
| May 19, 2022 Filed May 23, 2022 20:46 UTC |
Guerard FredericDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 33,357 | $0.90 | $30,057.99 |
DisclosureSEC source: 0001209191-22-031348 · doc4.xml · nonDerivative · entry 2 Guerard Frederic · CIK 0001825009 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,143 Read SEC document |
| May 19, 2022 Filed May 23, 2022 20:46 UTC |
Guerard FredericDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 112,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-031348 · doc4.xml · nonDerivative · entry 1 Guerard Frederic · CIK 0001825009 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.